Sign up to save your podcasts
Or
Share This Biotech CEO Is Using Neuroplastogenic Small-Molecule Therapeutics To Create Next Generation Mental Health. Dr Joseph Tucker – CEO Enveric $ENVB
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
This Biotech CEO Is Using Neuroplastogenic Small-Molecule Therapeutics To Create Next Generation Mental Health. Dr Joseph Tucker – CEO Enveric $ENVB
This Biotech CEO Is Using Neuroplastogenic Small-Molecule Therapeutics To Create Next Generation Mental Health. Dr Joseph Tucker – CEO Enveric $ENVB
Guest:
Dr. Joseph Tucker – CEO – Enveric Biosciences
Website:
https://www.enveric.com/
Company Bio:
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Dr. Tucker Bio:
Dr. Tucker is a seasoned executive who has built several publicly traded biotechnology companies. Dr. Tucker was a founder and Chief Executive Officer of Stem Cell Therapeutics, which he took public on the TSX (TSX: SSS). Trillium Therapeutics (NASDAQ: TRIL, TSX: TRIL) acquired Stem Cell Therapeutics in 2013. Dr. Tucker has also held the position of Co-Founder and Chief Executive Officer of Epimeron Inc., a University of Calgary start-up acquired in the creation of Willow Biosciences Inc. (TSX: WLLW). At Willow, Dr. Tucker served as Executive Chairman and Chief Operating Officer. Prior to founding companies, Dr. Tucker was a healthcare analyst with two investment banks and has also worked in technology commercialization for a university technology transfer office. Dr. Tucker received his Ph.D. in Biochemistry and Molecular Biology from the University of Calgary.
View all episodes
By Adam Sarhan
4.9
1515 ratings
This Biotech CEO Is Using Neuroplastogenic Small-Molecule Therapeutics To Create Next Generation Mental Health. Dr Joseph Tucker – CEO Enveric $ENVB
Guest:
Dr. Joseph Tucker – CEO – Enveric Biosciences
Website:
https://www.enveric.com/
Company Bio:
Enveric Biosciences, Inc., a biotechnology company, engages in the development of small-molecule therapeutics for the treatment of anxiety, depression, and addiction disorders. Its lead product candidates are EB-002, an active metabolite of psilocybin, which is in preclinical development stage for the treatment of anxiety disorders; and EB-003 that is in preclinical development stage for the treatment mental health. The company also focuses on the development of cannabinoid conjugate molecules for the treatment of pain and cancer. Enveric Biosciences, Inc. is headquartered in Naples, Florida.
Dr. Tucker Bio:
Dr. Tucker is a seasoned executive who has built several publicly traded biotechnology companies. Dr. Tucker was a founder and Chief Executive Officer of Stem Cell Therapeutics, which he took public on the TSX (TSX: SSS). Trillium Therapeutics (NASDAQ: TRIL, TSX: TRIL) acquired Stem Cell Therapeutics in 2013. Dr. Tucker has also held the position of Co-Founder and Chief Executive Officer of Epimeron Inc., a University of Calgary start-up acquired in the creation of Willow Biosciences Inc. (TSX: WLLW). At Willow, Dr. Tucker served as Executive Chairman and Chief Operating Officer. Prior to founding companies, Dr. Tucker was a healthcare analyst with two investment banks and has also worked in technology commercialization for a university technology transfer office. Dr. Tucker received his Ph.D. in Biochemistry and Molecular Biology from the University of Calgary.
More shows like Smart Money Circle
View all
InvestTalk
1,510 Listeners
Motley Fool Money
3,173 Listeners
Masters in Business
2,185 Listeners
We Study Billionaires - The Investor’s Podcast Network
3,367 Listeners
The Twenty Minute VC (20VC): Venture Capital | Startup Funding | The Pitch
504 Listeners
Investor's Edge with Gary Kaltbaum
166 Listeners
The Ben Shapiro Show
153,474 Listeners
Invest Like the Best with Patrick O'Shaughnessy
2,288 Listeners
Alpha Exchange
80 Listeners
Investing With IBD
382 Listeners
The Compound and Friends
2,049 Listeners
Verdict with Ted Cruz
44,188 Listeners
All-In with Chamath, Jason, Sacks & Friedberg
8,759 Listeners
The Megyn Kelly Show
38,292 Listeners
The Morgan Housel Podcast
985 Listeners